Whole-body MRI in erdheim-chester disease

Rheumatology

Volumn 51, Issue 5, 2012, Pages 948-950

  Arnaud, Laurent ^a   Bach, Gaëlle ^a   Zeitoun, Delphine ^a   Drier, Aurélie ^a   Cluzel, Philippe ^a   Grenier, Philippe A ^a   Amoura, Zahir ^a   Haroche, Julien ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ERDHEIM CHESTER DISEASE; HUMAN; LETTER; MAXILLARY SINUS; OSTEOSCLEROSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY MRI;

ERDHEIM-CHESTER DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84860244357     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes016     Document Type: Letter

References (1)

1. Arnaud L, Malek Z, Archambaud F et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 2009;60:3128-38.